- Associate Professor (University of Girona, 2022-2023)
- Research Technician (TargetsLab, 2022-2023)
- Ph.D. program in Molecular Biology, Biomedicine, and Health (University of Girona, 2018-2023)
- Predoctoral grant for the Recruitment of Novel Researcher (AGAUR-Generalitat de Catalunya) (TargetsLab-GREP, 2019)
- Predoctoral fellowship for the Recruitment of Predoctoral Researcher Personnel in Formation (IF_GR) (TargetsLab-GREP, 2018)
- Research Technician (TargetsLab, 2018)
- Master's degree in Molecular Biology and Biomedicine (University of Girona, 2017)
- Bachelor's degree in Biotechnology (University of Girona, 2016).
PUBLICATIONS:
- Polonio-Alcalá et al., Scientific Reports, 2022 (Q2, DOI: 10.1038/s41598-022-23655-2)
- Polonio-Alcalá et al., Biomedicine & Pharmacotherapy, 2022 (D1, DOI: 10.1016/j.biopha.2022.113942)
- Polonio-Alcalá et al., Cancer Communications, 2022 (D1, DOI: 10.1002/cac2.12282)
- Rabionet et al., Materials Today Bio, 2021 (Q1, DOI: 10.1016/j.mtbio.2021.100155)
- Polonio-Alcalá et al., Cancers, 2021 (Q1, DOI: 10.3390/cancers13215320)
- Polonio-Alcalá et al., Cancers, 2020 (Q1, DOI: 10.3390/cancers12051283)
- Polonio-Alcalá et al., Polymers, 2019 (Q1, DOI: 10.3390/polym11050916)
- Polonio-Alcalá et al., Current Drug Targets, 2019 (Q3, DOI: 10.2174/1389450120666181122113300)
- Polonio-Alcalá et al., International Journal of Molecular Sciences, 2018 (Q2, DOI: 10.3390/ijms19103148)
- Rabionet et al., Materials, 2018 (Q2, DOI: 10.3390/ma11081427)
PROCEEDINGS:
- Polonio et al., Journal of Thoracic Oncology, 2021 (D1, DOI: 10.1016/S1556-0864(21)01845-1)
- Polonio et al., Annals of Oncology, 2020 (D1, DOI: 10.1016/j.annonc.2020.08.1285)
- Polonio-Alcalá et al., American Journal of Computer Science and Information Technology, 2018 (DOI: 10.21767/2349-3917-C2-005)
- Giró-Perafita et al., International Journal of Molecular Medicine, 2017 (Q2)
CONGRESSES:
- Polonio et al., European Lung Cancer Virtual Congress 2021, Poster Communication, Switzerland (Virtual), 2021
- Polonio-Alcalá et al., 31st Conference of the European Society for Biomaterials (ESB2021), Oral Communication, Portugal, 2021
- Polonio et al., ESMO Virtual Congress 2020, Oral Communication, Switzerland (Virtual), 2020
- Rabionet et al., 30th Annual Conference of The European Society for Biomaterials, Poster Communication, Germany, 2019
- Polonio-Alcalá et al., EuroSciCon - 3D Printing and Wireless Technology, Oral Communication, Portugal, 2018
- Giró-Perafita et al., 22th World Congress on Advances in Oncology and 20th International Symposium on Molecular Medicine , Oral Communication, Greece, 2017
PROJECTS:
- ONCOen3D
- FASN inhibition: an alternative strategy to overcome resistance to EGFR Tyrosin Kinase Inhibitors in Non-squamous Non-Small Cell Lung Cancer. Funded by AstraZeneca.